DEC 12, 2017 6:16 AM PST

"Runx3" Protein Directs Killer Cells to Set Up Camp in Tumors

WRITTEN BY: Kara Marker

A certain type of T cells from the immune system is responsible for infiltrating cells infected by bacteria and viruses as well as cancerous cells that grow uncontrollably. These cells grow in numbers in the spleen and lymph nodes, but what signal indicates to the T cells that it’s time to move, either to infected tissues or to growing tumors?

 

Pigmented cells of a malignant melanoma metastasis. Credit: Wikimedia user Jensflorian

From the Scripps Research Institute, in a study published in Nature, scientists explore the movement of CD8+ T cells, or killer T cells.

The study began with the discovery of a protein called “Runx3,” which directs the movement of killer T cells, from the lymphoid system to tumors and infected tissues. Runx3 does this by interacting with chromosomes inside killer T cells, programming genes in such a way that killer T cells congregate in a solid tumor.

Thus, Runx3 could be useful in certain killer T cell-based cancer immunotherapies such as checkpoint inhibitor blockages, which promotes the accumulation of killer T cells in tumors, and adoptive cell transfer, which extracts, refines, and returns a cancer patient’s T cells to mount a specific and strengthened attack against a certain type of cancer.

In the past, adoptive cell transfer immunotherapy approaches were successful against blood cancer, not so much for solid tumors. But, improving the communication between killer T cells and Runx3 could potentially improve the anti-cancer efforts of the immune system.

“We could probably use Runx3 to reprogram adoptively transferred cells to help drive them to amass in solid tumors," explained Matthew Pipkin, PhD.

Pipkin’s study was a comparison of killer T cell gene expression from non-lymphoid tissue to gene expression from T cells in the circulation. Researchers found a “distinct pattern.”

"The screens showed that Runx3 is one at the top of a list of regulators essential for T cells to reside in nonlymphoid tissues,” Pipkin explained. Runx3 made certain genetic changes in killer T cells to draw them to tissues and tumors, genetic changes found in killer T cells that naturally reside in these places.

Next researchers designed killer T cells genetically altered to overexpress Runx3 and used them in adoptive cell transfer in mouse models of melanoma. These cells effectively inhibited cancer growth, and mice who received this treatment lived significantly longer compared to untreated mice.

Sources: Scripps Research Institute, British Society for Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
OCT 22, 2020
Immunology
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
OCT 22, 2020
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
Despite being commonly used interchangeably, headaches and migraines are worlds apart. Migraines are by far much more pr ...
OCT 27, 2020
Immunology
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
OCT 27, 2020
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
A recent study published in Immunity details MIT scientists’ exploration of the underlying mechanisms of inflammat ...
OCT 24, 2020
Immunology
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
OCT 24, 2020
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
A team of researchers at Duke University have developed an imaging technology for tagging structures at a cellular level ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 19, 2020
Immunology
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
NOV 19, 2020
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
Parasitic worms known as helminths have a complicated relationship with the immune systems of the hosts they invade. Ter ...
Loading Comments...